11.03.14
JAPAN: Histogen Aesthetics has entered into a licensing and distribution agreement with JPGH Co., Ltd. to bring CellCeuticals Regenerative Skin Treatments to Greater Asia.
JPGH, which is run by George Lee and John Paul Mitchell Systems (JPMS) co-founder, chairman and CEO John Paul Dejoria, will target the CellCeuticals line launch to Japan, Singapore, Indonesia, Malaysia, South Korea and Greater China (China, Taiwan, and Hong Kong).
CellCeuticals is a clinically-validated, premium line of skin care products based upon bioactive ingredients, such as proprietary growth factor lipopeptides, that have been shown to enhance skin rejuvenation and reverse the visible signs of aging.
“With regions like Korea and Japan moving to the forefront of stem cell and regenerative medicine, Asia is primed for a sophisticated beauty line based on cellular science,” said Lee. “Our experience and vast network tell us CellCeuticals is the right skin care line at the right time, and we believe it will be extremely well received.”
“Regenerative medicine holds the promise of many advancements in both aesthetic and therapeutic treatments,” said Dejoria. “We are excited to partner with Histogen Aesthetics.”
JPGH, which is run by George Lee and John Paul Mitchell Systems (JPMS) co-founder, chairman and CEO John Paul Dejoria, will target the CellCeuticals line launch to Japan, Singapore, Indonesia, Malaysia, South Korea and Greater China (China, Taiwan, and Hong Kong).
CellCeuticals is a clinically-validated, premium line of skin care products based upon bioactive ingredients, such as proprietary growth factor lipopeptides, that have been shown to enhance skin rejuvenation and reverse the visible signs of aging.
“With regions like Korea and Japan moving to the forefront of stem cell and regenerative medicine, Asia is primed for a sophisticated beauty line based on cellular science,” said Lee. “Our experience and vast network tell us CellCeuticals is the right skin care line at the right time, and we believe it will be extremely well received.”
“Regenerative medicine holds the promise of many advancements in both aesthetic and therapeutic treatments,” said Dejoria. “We are excited to partner with Histogen Aesthetics.”